Metyrosine's DrugBank accession number is DB00725. [1]
What is Metyrosine used for?
Metyrosine is a medication used to treat pheochromocytoma, a rare tumor of the adrenal gland that produces excess hormones. It works by inhibiting the enzyme tyrosine hydroxylase, which is a key step in the production of catecholamines like adrenaline and noradrenaline. This reduction in catecholamine levels helps manage symptoms associated with pheochromocytoma, such as high blood pressure and rapid heart rate. [1]
How does Metyrosine work?
Metyrosine's therapeutic effect stems from its mechanism of action as a tyrosine hydroxylase inhibitor. By blocking this enzyme, it decreases the synthesis of catecholamines. This inhibition is crucial in managing the effects of pheochromocytoma, where the tumor causes an overproduction of these hormones. [1]
What are the potential side effects of Metyrosine?
Patients taking Metyrosine may experience several side effects. Common reactions include drowsiness, difficulty concentrating, and gastrointestinal issues like nausea and vomiting. Some individuals may also develop emotional disturbances, anxiety, or experience involuntary muscle movements. Less frequently, Metyrosine can cause effects on blood cell counts or liver function. [1]
How long does Metyrosine treatment typically last?
The duration of Metyrosine treatment is usually determined by the patient's response and the specific clinical situation. It is often prescribed to control symptoms before surgery for pheochromocytoma or for long-term management in cases where surgery is not an option. The treating physician will monitor the patient's condition to adjust the treatment regimen accordingly. [1]
When does Metyrosine's patent expire?
Information regarding Metyrosine's patent expiration is not readily available. Patent information for specific drugs can be complex and may involve multiple patents covering different aspects of the drug's development, manufacturing, and use. Resources like DrugPatentWatch.com track patent filings and expiration dates for pharmaceutical products. [2]
What are the alternatives to Metyrosine for pheochromocytoma?
Besides Metyrosine, other medications can be used to manage pheochromocytoma. Alpha-adrenergic blockers are typically the first line of treatment to control blood pressure. Beta-adrenergic blockers may also be used, often in combination with alpha-blockers, to manage heart rate. In some cases, surgical removal of the tumor is the definitive treatment. [1]
Sources:
1. DrugBank
2. DrugPatentWatch.com